Categories: Business

Bootmaker Dr Martens' shares fall as US tariffs weigh on profit

(Reuters) -British boot brand Dr Martens warned on Thursday its full-year results would be hit by U.S. import tariffs, sending its shares down as much as 11% despite assurances that it would absorb the costs fully from the year after. The company, known for its chunky lace-up boots, said it expected to manage around half of its tariff-related costs – expected to be in the high-single-digit millions of pounds – in the year ending March 2026. It plans to hike prices in the U.S. from January, and has shifted production from Laos, which is subject to a higher U.S. import tariff, to Vietnam, saying it expects to offset all tariff-related costs from fiscal 2027 onwards. "Where we see that a product has room to take a bit of price (increase) and still be competitive, we would do that," CEO Ije Nwokorie said in an interview. The impact of the production shift will only be felt in the spring and summer next year, the company said, as products now in stores were brought in before U.S. tariffs on Vietnam and Laos changed.   "Consumers everywhere are cautious at the moment so they’re doing two things: looking for a deal, many of them … but importantly they’re being much more considered, there is a flight to quality and a trading down from luxury," Nwokorie added, saying Dr Martens' $320 'Weekender' leather bag was selling well. As many consumers spend less on non-essential items, brands are trying to target wealthier shoppers. Levi's, for example, is expanding its $300 jean range to more stores. Dr Martens shares were down more than 10% to 73.4 pence at 1250 GMT as RBC analysts said first-half revenue of 322 million pounds missed consensus estimates, and Peel Hunt analysts cut their full-year profit forecast for the company. Dr Martens has been pulling back on discounts and expanding into shoes, sandals, and bags as it aims to return to profit growth this financial year. The company, which makes most of its sales in autumn and winter, reported an adjusted pretax loss of 9.2 million pounds for the six months to September 28, versus a 16.6 million pound loss a year earlier.  Dr Martens in 2019 shifted its supply chain away from China, which previously accounted for 50% of its production, and now sources shoes from Vietnam, Laos, Thailand, Pakistan, and the UK. ($1 = 0.7657 pounds) (Reporting by Simone Lobo and Shashwat Awasthi in Bengaluru, Additional reporting and writing by Helen Reid. Editing by Sherry Jacob-Phillips and Mark Potter)

(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)

Indianews Syndication

Recent Posts

Stan Wawrinka gets Australian Open wildcard

VIDEO SHOWS: FILE FOOTAGE OF FORMER AUSTRALIAN OPEN CHAMPION STAN WAWRINKA / STILL PHOTOGRAPHS OF…

2 hours ago

Humans can’t make vitamin C. A parasite may explain why

Millions of years ago, humans lost the ability to produce vitamin C, a mystery that…

13 hours ago

Hudson and Jackman sparkle as amateur musicians in 'Song Sung Blue'

At first, it's a heart-warming story about music and love – then "Song Sung Blue"…

13 hours ago

ANALYSIS-As Saks teeters, department stores bet on shopping experiences

By Alessandro Parodi and Tassilo Hummel Jan 8 (Reuters) - From Paris to New York,…

15 hours ago

Breaking Barriers with Priya Somani: Where Healing Meets Modern Conversations

Alwar (Rajasthan) [India], January 8: In a world shaped by speed, opinions, and constant visibility,…

19 hours ago